UK home dialysis move to boost expansion
This article was originally published in Clinica
Executive Summary
Last week's recommendation by the UK's National Institute for Clinical Excellence (NICE) that all suitable patients with end-stage renal failure (ESRF) be given the option of receiving haemodialysis at home is expected to result in a shift of 10-15% of patients to this service. Renal services in England and Wales will need to expand to meet this demand, says NICE. The majority of renal units in England already offer a home haemodialysis service, but uptake levels vary widely and only a small number of centres have up to 15% uptake. A move towards this would release resources for patients who are unsuitable for home dialysis.
You may also be interested in...
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.